Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Flu vaccines pass €1 billion in Sanofi-Aventis's Q4

This article was originally published in Scrip

Executive Summary

Sanofi-Aventis has reported a 10% increase in its fourth-quarter net income as sales of its influenza vaccines grew to almost €1.1 billion. The French firm's human vaccines business expanded by 65% in the quarter, pushing group net income to €1.8 billion. More to follow.